glycyrrhizic acid has been researched along with Hepatitis B in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, Q; Liu, J; Liu, W; Ni, P; Sang, G; Wang, G; Wang, W; Zhang, J; Zhou, F | 1 |
| Bleiberg, H; Gerard, B | 1 |
| Ikeda, K; Koyake, E; Kumada, H; Yoshiba, A; Yoshida, Y | 1 |
| Shiraki, K; Takahara, T; Watanabe, A | 1 |
| Ishikawa, H; Kakisaka, Y; Kashima, K; Mitsuyoshi, H; Nakajima, Y; Nakamura, H; Nakashima, T; Sumida, Y; Yodoi, J; Yoh, T | 1 |
| Fujii, N; Harada, M; Kiura, K; Matsuo, K; Shimomura, H; Shinagawa, K; Takenaka, K | 1 |
| Eisenburg, J | 1 |
| Hayashi, J; Hayashi, S; Hirata, M; Kajiyama, W; Kashiwagi, S; Nakashima, K; Noguchi, A | 1 |
| Kobayashi, M; Koike, M; Miyashiro, E; Sumiyama, K | 1 |
| Hayashi, J; Ikematsu, H; Kashiwagi, S; Motomura, M; Noguchi, A; Tsuda, H; Tsuji, Y | 1 |
| Arima, T; Nagashima, H; Wada, T | 1 |
| Yang, ZH; Zhang, ZH | 1 |
1 review(s) available for glycyrrhizic acid and Hepatitis B
| Article | Year |
|---|---|
Treatment of hepatocarcinoma.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Cryotherapy; Drug Therapy, Combination; Ethanol; Glycyrrhizic Acid; Hepatitis B; Humans; Interferon-alpha; Liver Neoplasms; Liver Transplantation; Risk Factors; Survival Rate | 2004 |
1 trial(s) available for glycyrrhizic acid and Hepatitis B
| Article | Year |
|---|---|
[Treatment of chronic hepatitis B. Part 2: Effect of glycyrrhizic acid on the course of illness].
Topics: Adult; Aged; Antiviral Agents; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Male; Middle Aged | 1992 |
10 other study(ies) available for glycyrrhizic acid and Hepatitis B
| Article | Year |
|---|---|
Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibition.
Topics: Animals; Antiviral Agents; Cells, Cultured; DNA, Viral; Drug Interactions; Glycyrrhetinic Acid; Glycyrrhizic Acid; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Liver; Male; Membrane Transport Proteins; Mice, Transgenic; Rats, Sprague-Dawley | 2017 |
[Study on frequency of the eAg-eAb seroconversion by corticosteroid and glycyrrhizin in eAg positive chronic hepatitis (author's transl)].
Topics: Adrenal Cortex Hormones; Antibodies, Viral; Chronic Disease; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Humans | 1981 |
Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study.
Topics: Antiviral Agents; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B Surface Antigens; Humans; In Vitro Techniques; Microscopy, Electron; Microscopy, Immunoelectron; Tumor Cells, Cultured | 1994 |
Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid.
Topics: Adult; Aged; Case-Control Studies; Female; Glycyrrhizic Acid; Hepatitis B; Hepatitis C; Humans; Indocyanine Green; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; Thioredoxins; Ursodeoxycholic Acid | 2000 |
Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma.
Topics: Anti-HIV Agents; Antineoplastic Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Glycyrrhizic Acid; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Testicular Neoplasms; Virus Activation | 2001 |
Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B.
Topics: Adult; Antiviral Agents; Drug Administration Schedule; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Interferon-alpha; Male | 1991 |
Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive).
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Combined Modality Therapy; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B e Antigens; Hepatitis, Chronic; Humans; Infant; Injections, Intravenous; Male; Oleanolic Acid; Solutions; Time Factors; Transfer Factor | 1991 |
Combination therapy of glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Chronic Disease; DNA-Directed DNA Polymerase; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B Antigens; Hepatitis B Surface Antigens; Humans; Interferon-gamma; Male; Middle Aged | 1989 |
Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.
Topics: Adult; Carcinoma, Hepatocellular; Chronic Disease; Cytotoxicity, Immunologic; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Humans; Interferon Type I; Killer Cells, Natural; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Picibanil; Radioimmunoassay; Skin Tests; Vidarabine | 1987 |
[Effect of adenine-arabinosine with glycyrrhizin in treating chronic active hepatitis].
Topics: Adolescent; Adult; Antiviral Agents; Combined Modality Therapy; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis, Chronic; Humans; Male; Vidarabine | 1988 |